Celgene Corporation
Jul 16, 2012
PDF
Add to Briefcase

Celgene Corporation to Announce Second Quarter 2012 Results on July 26, 2012

SUMMIT, N.J.--(BUSINESS WIRE)--Jul. 16, 2012-- Celgene Corporation (NASDAQ: CELG) senior management will host a conference call and live audio webcast on Thursday, July 26, 2012 at 9 a.m. ET to discuss the company’s second quarter 2012 financial and operational results. The webcast will be available in the investor relations section of the Company’s Web site at www.celgene.com.

About Celgene

Celgene Corporation, headquartered in Summit, New Jersey, is an integrated global biopharmaceutical company engaged primarily in the discovery, development and commercialization of novel therapies for the treatment of cancer and inflammatory diseases through gene and protein regulation. For more information, please visit the company’s Web site at www.celgene.com.

Source: Celgene Corporation

Celgene Corporation
Jacqualyn A. Fouse
Executive Vice President and Chief Financial Officer
908-673-9956
or
Patrick E. Flanigan III
Vice President
Investor Relations
908-673-9969